 Hollis Karoly
Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 16 | 2025 | 510 | 4.700 |
Why?
| | Alcohol Drinking | 19 | 2026 | 843 | 4.380 |
Why?
| | Cannabidiol | 7 | 2026 | 142 | 3.450 |
Why?
| | Ethanol | 12 | 2026 | 631 | 3.170 |
Why?
| | Hallucinogens | 6 | 2026 | 111 | 2.870 |
Why?
| | Alcoholism | 11 | 2026 | 826 | 2.460 |
Why?
| | Marijuana Abuse | 7 | 2025 | 214 | 2.260 |
Why?
| | Substance-Related Disorders | 11 | 2025 | 1102 | 2.020 |
Why?
| | Cannabinoids | 5 | 2022 | 184 | 2.020 |
Why?
| | Reagent Strips | 2 | 2025 | 8 | 1.790 |
Why?
| | Adolescent Behavior | 6 | 2019 | 497 | 1.630 |
Why?
| | Substance Abuse Detection | 2 | 2025 | 110 | 1.610 |
Why?
| | Fentanyl | 2 | 2025 | 128 | 1.600 |
Why?
| | Brain | 10 | 2025 | 2969 | 1.540 |
Why?
| | Gray Matter | 4 | 2021 | 92 | 1.290 |
Why?
| | Marijuana Smoking | 5 | 2023 | 249 | 1.280 |
Why?
| | Marijuana Use | 5 | 2025 | 222 | 1.200 |
Why?
| | Harm Reduction | 3 | 2026 | 49 | 1.160 |
Why?
| | Neuroimaging | 3 | 2024 | 300 | 1.130 |
Why?
| | Magnetic Resonance Imaging | 13 | 2025 | 3915 | 1.100 |
Why?
| | Cues | 5 | 2019 | 329 | 0.990 |
Why?
| | Tea | 1 | 2026 | 17 | 0.940 |
Why?
| | Mitragyna | 1 | 2026 | 8 | 0.940 |
Why?
| | Psilocybin | 1 | 2026 | 5 | 0.930 |
Why?
| | Toll-Like Receptor 4 | 2 | 2018 | 276 | 0.930 |
Why?
| | Verbal Learning | 2 | 2025 | 72 | 0.920 |
Why?
| | Product Labeling | 1 | 2025 | 11 | 0.900 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2025 | 33 | 0.880 |
Why?
| | Music | 1 | 2025 | 48 | 0.840 |
Why?
| | Dronabinol | 7 | 2026 | 249 | 0.820 |
Why?
| | Memory | 1 | 2025 | 297 | 0.760 |
Why?
| | Alcohol-Related Disorders | 4 | 2021 | 121 | 0.730 |
Why?
| | White Matter | 2 | 2021 | 155 | 0.720 |
Why?
| | Young Adult | 19 | 2026 | 14250 | 0.690 |
Why?
| | Reward | 4 | 2018 | 248 | 0.690 |
Why?
| | Behavior, Addictive | 3 | 2019 | 88 | 0.650 |
Why?
| | Adult | 28 | 2026 | 40867 | 0.650 |
Why?
| | Public Health | 1 | 2026 | 574 | 0.640 |
Why?
| | Humans | 56 | 2026 | 145750 | 0.630 |
Why?
| | Alcoholic Intoxication | 1 | 2021 | 76 | 0.610 |
Why?
| | Adolescent Development | 1 | 2019 | 72 | 0.570 |
Why?
| | Avoidance Learning | 1 | 2019 | 63 | 0.570 |
Why?
| | Therapy, Computer-Assisted | 1 | 2019 | 63 | 0.570 |
Why?
| | Students | 2 | 2025 | 652 | 0.560 |
Why?
| | Adolescent | 17 | 2026 | 22569 | 0.530 |
Why?
| | Arousal | 1 | 2018 | 157 | 0.530 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 204 | 0.510 |
Why?
| | Flowers | 3 | 2023 | 61 | 0.500 |
Why?
| | Opioid-Related Disorders | 1 | 2025 | 605 | 0.490 |
Why?
| | Male | 35 | 2026 | 72992 | 0.490 |
Why?
| | Female | 35 | 2026 | 79025 | 0.480 |
Why?
| | Risk-Taking | 2 | 2018 | 323 | 0.470 |
Why?
| | Affect | 1 | 2018 | 321 | 0.460 |
Why?
| | Drug Users | 1 | 2015 | 43 | 0.440 |
Why?
| | Cannabinoid Receptor Agonists | 4 | 2023 | 44 | 0.440 |
Why?
| | Cytokines | 2 | 2025 | 2069 | 0.430 |
Why?
| | Sexual Behavior | 2 | 2018 | 495 | 0.430 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 135 | 0.400 |
Why?
| | Motivation | 1 | 2018 | 601 | 0.400 |
Why?
| | Colorado | 4 | 2026 | 4556 | 0.400 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2013 | 47 | 0.380 |
Why?
| | Cross-Over Studies | 2 | 2026 | 610 | 0.360 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 768 | 0.340 |
Why?
| | Parenting | 1 | 2015 | 319 | 0.330 |
Why?
| | Extinction, Psychological | 1 | 2012 | 92 | 0.320 |
Why?
| | Universities | 2 | 2023 | 445 | 0.320 |
Why?
| | Analgesics | 2 | 2022 | 231 | 0.300 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2024 | 655 | 0.300 |
Why?
| | Double-Blind Method | 3 | 2023 | 2064 | 0.250 |
Why?
| | Psychomotor Performance | 2 | 2020 | 324 | 0.250 |
Why?
| | Tobacco Use | 2 | 2019 | 62 | 0.250 |
Why?
| | Delay Discounting | 2 | 2018 | 29 | 0.240 |
Why?
| | Kava | 1 | 2026 | 3 | 0.240 |
Why?
| | Ethnobotany | 1 | 2026 | 1 | 0.240 |
Why?
| | Smoking | 3 | 2018 | 1477 | 0.240 |
Why?
| | Executive Function | 3 | 2020 | 470 | 0.230 |
Why?
| | Self Administration | 1 | 2026 | 122 | 0.230 |
Why?
| | Enzyme Multiplied Immunoassay Technique | 1 | 2025 | 2 | 0.230 |
Why?
| | Surveys and Questionnaires | 4 | 2026 | 6084 | 0.220 |
Why?
| | Tobacco Use Disorder | 2 | 2017 | 217 | 0.200 |
Why?
| | Mental Recall | 1 | 2025 | 223 | 0.200 |
Why?
| | Middle Aged | 11 | 2025 | 36297 | 0.190 |
Why?
| | Stress, Psychological | 1 | 2012 | 1149 | 0.190 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2018 | 430 | 0.190 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5921 | 0.180 |
Why?
| | Exercise | 2 | 2020 | 2203 | 0.180 |
Why?
| | Biomarkers | 2 | 2025 | 4302 | 0.180 |
Why?
| | Sex Factors | 2 | 2025 | 2110 | 0.170 |
Why?
| | Self Report | 2 | 2018 | 875 | 0.170 |
Why?
| | Nerve Net | 2 | 2015 | 286 | 0.170 |
Why?
| | Psychomotor Disorders | 1 | 2020 | 15 | 0.160 |
Why?
| | Phenotype | 3 | 2026 | 3170 | 0.160 |
Why?
| | Mindfulness | 1 | 2023 | 136 | 0.160 |
Why?
| | Inflammation | 2 | 2025 | 2883 | 0.160 |
Why?
| | High-Intensity Interval Training | 1 | 2020 | 45 | 0.160 |
Why?
| | Sensation Disorders | 1 | 2020 | 40 | 0.160 |
Why?
| | Indians, North American | 1 | 2025 | 598 | 0.150 |
Why?
| | Animals | 6 | 2026 | 38100 | 0.140 |
Why?
| | Research Design | 1 | 2025 | 1139 | 0.140 |
Why?
| | Plant Extracts | 1 | 2020 | 188 | 0.140 |
Why?
| | DNA Methylation | 3 | 2018 | 690 | 0.140 |
Why?
| | Photic Stimulation | 1 | 2019 | 264 | 0.130 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 428 | 0.130 |
Why?
| | Varenicline | 1 | 2017 | 28 | 0.130 |
Why?
| | Receptors, Dopamine D2 | 1 | 2018 | 93 | 0.130 |
Why?
| | Methylation | 1 | 2017 | 242 | 0.120 |
Why?
| | Interleukin-8 | 1 | 2018 | 269 | 0.120 |
Why?
| | Saliva | 1 | 2018 | 249 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2018 | 179 | 0.120 |
Why?
| | Interleukin-1beta | 1 | 2018 | 389 | 0.120 |
Why?
| | United States | 3 | 2026 | 16122 | 0.110 |
Why?
| | Pregnancy | 3 | 2024 | 7215 | 0.110 |
Why?
| | Anticipation, Psychological | 1 | 2015 | 20 | 0.110 |
Why?
| | Brain Mapping | 1 | 2018 | 542 | 0.110 |
Why?
| | Exploratory Behavior | 1 | 2015 | 85 | 0.110 |
Why?
| | Heart Rate | 1 | 2018 | 856 | 0.110 |
Why?
| | Cerebral Cortex | 1 | 2018 | 474 | 0.110 |
Why?
| | Comorbidity | 1 | 2019 | 1662 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2020 | 468 | 0.100 |
Why?
| | Functional Neuroimaging | 1 | 2014 | 61 | 0.100 |
Why?
| | Retinal Dehydrogenase | 1 | 2013 | 29 | 0.100 |
Why?
| | Drug Interactions | 1 | 2015 | 405 | 0.100 |
Why?
| | Interleukin-6 | 1 | 2018 | 779 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 441 | 0.100 |
Why?
| | Benzodiazepines | 1 | 2014 | 168 | 0.100 |
Why?
| | Pilot Projects | 1 | 2019 | 1897 | 0.100 |
Why?
| | Antipsychotic Agents | 1 | 2014 | 211 | 0.090 |
Why?
| | Blood Pressure | 1 | 2018 | 1782 | 0.090 |
Why?
| | Receptors, Nicotinic | 1 | 2014 | 327 | 0.090 |
Why?
| | Genetic Association Studies | 1 | 2013 | 371 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 782 | 0.080 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1327 | 0.080 |
Why?
| | Siblings | 2 | 2018 | 196 | 0.060 |
Why?
| | Child | 2 | 2024 | 22738 | 0.060 |
Why?
| | Parents | 1 | 2015 | 1404 | 0.060 |
Why?
| | Half-Life | 1 | 2026 | 155 | 0.060 |
Why?
| | Anxiety | 2 | 2023 | 1122 | 0.060 |
Why?
| | Area Under Curve | 1 | 2026 | 332 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2017 | 11793 | 0.050 |
Why?
| | Connectome | 1 | 2025 | 96 | 0.050 |
Why?
| | Schools | 1 | 2025 | 449 | 0.040 |
Why?
| | Intention | 1 | 2023 | 186 | 0.040 |
Why?
| | Signal Transduction | 1 | 2015 | 5223 | 0.040 |
Why?
| | Secondary Prevention | 1 | 2023 | 251 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2023 | 371 | 0.040 |
Why?
| | Underage Drinking | 1 | 2019 | 22 | 0.040 |
Why?
| | Prevalence | 1 | 2025 | 2874 | 0.030 |
Why?
| | Hyperkinesis | 1 | 2017 | 16 | 0.030 |
Why?
| | Missouri | 1 | 2017 | 66 | 0.030 |
Why?
| | Southwestern United States | 1 | 2017 | 93 | 0.030 |
Why?
| | Postural Balance | 1 | 2020 | 246 | 0.030 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2018 | 232 | 0.030 |
Why?
| | Attention | 1 | 2020 | 463 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 461 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2020 | 475 | 0.030 |
Why?
| | Impulsive Behavior | 1 | 2017 | 145 | 0.030 |
Why?
| | Taste | 1 | 2018 | 238 | 0.030 |
Why?
| | Conduct Disorder | 1 | 2017 | 158 | 0.030 |
Why?
| | Bayes Theorem | 1 | 2017 | 421 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2013 | 17322 | 0.030 |
Why?
| | Craving | 1 | 2014 | 40 | 0.030 |
Why?
| | CpG Islands | 1 | 2013 | 171 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1247 | 0.020 |
Why?
| | Mothers | 1 | 2017 | 765 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2028 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2933 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5428 | 0.020 |
Why?
| | Cohort Studies | 1 | 2017 | 6032 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3346 | 0.010 |
Why?
| | Aged | 1 | 2020 | 26212 | 0.010 |
Why?
| | Cephalosporins | 1 | 1978 | 45 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1978 | 563 | 0.000 |
Why?
| | Microbial Sensitivity Tests | 1 | 1978 | 365 | 0.000 |
Why?
| | Bacterial Infections | 1 | 1978 | 246 | 0.000 |
Why?
| | Bacteria | 1 | 1978 | 766 | 0.000 |
Why?
| | Mice | 1 | 1978 | 18357 | 0.000 |
Why?
|
|
Karoly's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|